No insider purchase over the last 90 days. The latest was filed 27 May 2026.
TS Trillion Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). Over the twelve months to 18 October 2026, the company's managers filed 17 filings, from 9 insiders.
Both sides are active: 9 purchases and 7 sales worth €7.3M, from 6 insiders and 7 insiders respectively. The totals do not cover 15 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 2 board members and 1 chief executive. 장기영 filed the largest sale, €7.3M, on 20 April 2026, which represents 34.1% of the company's market value.
With 17 filings in twelve months, the company is more active than the median of 7 filings across the 2,628 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 76 purchases and 8 sales.
The most recent open-market purchase was published on 27 July 2026, 83 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 6 days. Until a filing is published, the market cannot know about the trade.
In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
+1 other insider
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 112 declarations
TS트릴리온 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.
Insider filings
Over the last 90 days, 5 filings published between 27 July and 13 October 2026: 1 open-market purchase by insiders (amount not disclosed). 4 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 16 October 2026 (UTC)